SCHEMBL19046022

SCHEMBL19046022

CC1(C)Cc2ccc(N3CCC4(CC3)CNC4)cc2O1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 3/20 0.35
▸ USP2 O75604 5/20 0.34
▸ CYP2D6 P10635 5/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ CYP1A2 P05177 4/20 0.34
▸ TP53 P04637 3/20 0.34
▸ CYP3A4 P08684 3/20 0.34
▸ MAPK1 P28482 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ SLC6A2 P23975 2/20 0.33
▸ SLC6A4 P31645 2/20 0.33
▸ SLC6A3 Q01959 2/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ IRAK4 Q9NWZ3 3/20 0.33
▸ HPGD P15428 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19046180 0.77 IRAK4 (0.46) OGACYP2D6CYP1A2CYP3A4HSD17B10
SCHEMBL23277934 0.74 IRAK4 (0.47) IRAK4
SCHEMBL19045415 0.74 GPR183 (0.45) ALDH1A1TSHRSMN1; SMN2
SCHEMBL19046023 0.73 IRAK4 (0.40) IRAK4
SCHEMBL19045021 0.73 IRAK4 (0.42) OGAALDH1A1HSD17B10SLC6A4IRAK4
SCHEMBL19030571 0.72 IRAK4 (0.38) CYP2D6ALDH1A1CYP1A2FFAR4CYP2C19
SCHEMBL19046001 0.72 IRAK4 (0.43) OGAALDH1A1HSD17B10IRAK4SMN1; SMN2
SCHEMBL24123989 0.69 ADRB1 (0.58) USP2CYP2D6ALDH1A1CYP1A2TP53
SCHEMBL4237240 0.66 CCR8 (0.61) USP2CYP2D6ALDH1A1CYP3A4TSHR
SCHEMBL31341893 0.66 HTR3E (0.58) USP2CYP2D6ALDH1A1CYP1A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017108723-A2 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2017-06-29 — — WO disclosed
Send feedback